Click Here for 5% Off Your First Aladdin Purchase!

Recombinant Wilms Tumor Protein Antibody - Primary antibody, specific to Wilms Tumor Protein, Rabbit IgG

  • ExactAb™
  • Recombinant
  • Validated
  • 0.6 mg/mL
Features and benefits
  • Short Overview:

    Recombinant; Rabbit anti Human Wilms Tumor Protein Antibody; WB, IHC; Unconjugated

  • Species reactivity(Reacts with): Human,Mouse
  • Isotype: Rabbit IgG
    Application:
  • IHC
  • WB
Item Number
Ab134682
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab134682-10μl
10μl
In stock
$66.90
Ab134682-50μl
50μl
In stock
$199.90
Ab134682-100μl
100μl
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$339.90
Ab134682-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,399.90

Recombinant; Rabbit anti Human Wilms Tumor Protein Antibody; WB, IHC; Unconjugated

Basic Description

Product NameRecombinant Wilms Tumor Protein Antibody - Primary antibody, specific to Wilms Tumor Protein, Rabbit IgG
SynonymsWIT 2 antibody; WT 1 antibody; AWT1 antibody; FWT1 antibody; GUD antibody; NPHS4 antibody; WAGR antibody; Wilms tumor 1 antibody; Wilms Tumor antibody; Wilms tumor protein antibody; Wilms' tumor gene antibody; Wilms' tumor protein antibody; WIT2 antibody;
Specifications & PurityExactAb™, Validated, Recombinant, 0.6 mg/mL
Host speciesRabbit
SpecificityWilms Tumor Protein
ImmunogenA synthetic peptide derived from human Wilms Tumor Protein (AA 60-250)
Positive ControlWB: K562, A549 and HEK293 cell lysates. IHC: Mouse kidney tissue.
ConjugationUnconjugated
GradeExactAb™, Recombinant, Validated
Product Description

Rabbit anti Human Wilms Tumor Protein Antibody, Recombinant, could be used for WB, IHC and so on.
Application
WB: 1/500-1/1000
IHC: 1/50-/100
Protein Function
Transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA.

Product Properties

IsotypeRabbit IgG
Light Chain Typekappa
SDS-PAGE150 kDa
Purification MethodProtein A purified
FormLiquid
Concentration0.6 mg/mL
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle.

Images

Recombinant Wilms Tumor Protein Antibody (Ab134682) - Western Blot
All lanes: Recombinant Wilms Tumor Protein Antibody (Ab134682) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution

Predicted band size: 49 kDa
Observed band size: 54 kDa
Exposure time: 100.0 s

Recombinant Wilms Tumor Protein Antibody (Ab134682) - Western Blot
All lanes: Recombinant Wilms Tumor Protein Antibody (Ab134682) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution

Predicted band size: 49 kDa
Observed band size: 52, 60 kDa
Exposure time: 52.9 s


Recombinant Wilms Tumor Protein Antibody (Ab134682) - IHC
Immunohistochemistry analysis of paraffin-embedded mouse kidney using Recombinant Wilms Tumor Protein Antibody (Ab134682). High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.

Associated Targets

WT1 Tbio Wilms tumor protein 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Application

ApplicationDilution info
WB

1/500-1/1000

IHC

1/50 - 1/100

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

2 results found

Lot NumberCertificate TypeDateItem
ZJ24F0202810Certificate of AnalysisFeb 21, 2024 Ab134682
ZJ24F0202809Certificate of AnalysisFeb 21, 2024 Ab134682

Related Documents

References

1. Todd D Taylor,Hideki Noguchi,Yasushi Totoki,Atsushi Toyoda,Yoko Kuroki,Ken Dewar,Christine Lloyd,Takehiko Itoh,Tadayuki Takeda,Dae-Won Kim,Xinwei She,Karen F Barlow,Toby Bloom,Elspeth Bruford,Jean L Chang,Christina A Cuomo,Evan Eichler,Michael G FitzGerald,David B Jaffe,Kurt LaButti,Robert Nicol,Hong-Seog Park,Christopher Seaman,Carrie Sougnez,Xiaoping Yang,Andrew R Zimmer,Michael C Zody,Bruce W Birren,Chad Nusbaum,Asao Fujiyama,Masahira Hattori,Jane Rogers,Eric S Lander,Yoshiyuki Sakaki.  (2006-03-24)  Human chromosome 11 DNA sequence and analysis including novel gene identification..  Nature,  440  ((7083)): (497-500).  [PMID:16554811]
2. Bruening, W W and 7 more authors..  (1992)  Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development..  Nature genetics,      [PMID:1302008]
3. Haber, D A DA and Buckler, A J AJ..  (1992)  WT1: a novel tumor suppressor gene inactivated in Wilms' tumor..  The New biologist,      [PMID:1313285]
4. Little, M H MH and 5 more authors..  (1992)  Zinc finger point mutations within the WT1 gene in Wilms tumor patients..  Proceedings of the National Academy of Sciences of the United States of America,    (1):   [PMID:1317572]
5. Baird, P N PN, Santos, A A, Groves, N N, Jadresic, L L and Cowell, J K JK..  (1992)  Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome..  Human molecular genetics,      [PMID:1338906]
6. Gessler, M M, König, A A and Bruns, G A GA..  (1992)  The genomic organization and expression of the WT1 gene..  Genomics,      [PMID:1572653]
7. Pelletier, J J and 5 more authors..  (1991)  WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour..  Nature,    (3):   [PMID:1654525]
8. Pelletier, J J and 9 more authors..  (1991)  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome..  Cell,    (18):   [PMID:1655284]
9. Haber, D A DA and 5 more authors..  (1991)  Alternative splicing and genomic structure of the Wilms tumor gene WT1..  Proceedings of the National Academy of Sciences of the United States of America,    (1):   [PMID:1658787]
10. Buckler, A J AJ, Pelletier, J J, Haber, D A DA, Glaser, T T and Housman, D E DE..  (1991)  Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development..  Molecular and cellular biology,      [PMID:1671709]
11. Call, K M KM and 9 more authors..  (1990)  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus..  Cell,    (9):   [PMID:2154335]
12. Gessler, M M and 5 more authors..  (1990)  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping..  Nature,    (22):   [PMID:2154702]
13. Hamilton, T B TB, Barilla, K C KC and Romaniuk, P J PJ..  (1995)  High affinity binding sites for the Wilms' tumour suppressor protein WT1..  Nucleic acids research,    (25):   [PMID:7862533]
14. Sharma, P M PM, Bowman, M M, Madden, S L SL, Rauscher, F J FJ and Sukumar, S S..  (1994)  RNA editing in the Wilms' tumor susceptibility gene, WT1..  Genes & development,    (15):   [PMID:7926762]
15. Nordenskjöld, A A, Friedman, E E and Anvret, M M..  (1994)  WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin..  Human genetics,      [PMID:8112732]
16. Tsuda, M M and 7 more authors..  (1993)  Molecular analysis of two Japanese cases of Denys-Drash syndrome..  Journal of inherited metabolic disease,      [PMID:8295405]
17. Little, M H MH and 6 more authors..  (1993)  Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion..  Human molecular genetics,      [PMID:8388765]
18. and Rauscher, F J FJ..  (1993)  The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor..  FASEB journal : official publication of the Federation of American Societies for Experimental Biology,      [PMID:8393820]
19. Park, S S and 9 more authors..  (1993)  The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma..  Nature genetics,      [PMID:8401592]
20. Clarkson, P A PA and 5 more authors..  (1993)  Mutational screening of the Wilms's tumour gene, WT1, in males with genital abnormalities..  Journal of medical genetics,      [PMID:8411073]
21. Bruening, W W and Pelletier, J J..  (1996)  A non-AUG translational initiation event generates novel WT1 isoforms..  The Journal of biological chemistry,    (12):   [PMID:8621495]
22. Tsuda, M M, Sakiyama, T T, Owada, M M and Chiba, Y Y..  (1996)  A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome..  Acta paediatrica Japonica : Overseas edition,      [PMID:8741319]
23. Ghahremani, M M and 5 more authors..  ()  A novel mutation H373Y in the Wilms' tumor suppressor gene, WT1, associated with Denys-Drash syndrome..  Human heredity,      [PMID:8956030]
24. Schumacher, V V and 8 more authors..  (1997)  Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology..  Proceedings of the National Academy of Sciences of the United States of America,    (15):   [PMID:9108089]
25. Kikuchi, H H and 8 more authors..  (1998)  Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome?.  Journal of medical genetics,      [PMID:9475094]
26. Jeanpierre, C C and 11 more authors..  (1998)  Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database..  American journal of human genetics,      [PMID:9529364]
27. Schumacher, V V and 15 more authors..  (1998)  Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations..  Kidney international,      [PMID:9607189]
28. Kohsaka, T T and 5 more authors..  (1999)  Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome..  Human mutation,      [PMID:10571943]
29. Little, M M, Carman, G G and Donaldson, E E..  (2000)  Novel WT1 exon 9 mutation (D396Y) in a patient with early onset Denys Drash syndrome..  Human mutation,      [PMID:10738002]
30. Ohta, S S, Ozawa, T T, Izumino, K K, Sakuragawa, N N and Fuse, H H..  (2000)  A novel missense mutation of the Wt1 gene causing Denys-Drash syndrome with exceptionally mild renal manifestations..  The Journal of urology,      [PMID:10799199]
31. Little, N A NA, Hastie, N D ND and Davies, R C RC..  (2000)  Identification of WTAP, a novel Wilms' tumour 1-associating protein..  Human molecular genetics,    (22):   [PMID:11001926]
32. Takata, A A and 5 more authors..  (2000)  Constitutional WT1 correlate with clinical features in children with progressive nephropathy..  Journal of medical genetics,      [PMID:11182928]
33. Swiatecka-Urban, A A, Mokrzycki, M H MH, Kaskel, F F, Da Silva, F F and Denamur, E E..  (2001)  Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome..  Pediatric nephrology (Berlin, Germany),      [PMID:11519891]
34. Lee, Tae Ho TH, Lwu, Shelly S, Kim, Jungho J and Pelletier, Jerry J..  (2002)  Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor..  The Journal of biological chemistry,    (22):   [PMID:12239212]
35. Matsuzawa-Watanabe, Yumiko Y, Inoue, Jun-Ichiro J and Semba, Kentaro K..  (2003)  Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1..  Oncogene,    (11):   [PMID:12970737]
36. Royer-Pokora, Brigitte B and 6 more authors..  (2004)  Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development..  American journal of medical genetics. Part A,    (15):   [PMID:15150775]
37. Ruf, Rainer G RG and 16 more authors..  (2004)  Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome..  Kidney international,      [PMID:15253707]
38. Wang, Yanping Y and 9 more authors..  (2004)  Mutation analysis of five candidate genes in Chinese patients with hypospadias..  European journal of human genetics : EJHG,      [PMID:15266301]
39. Hu, Min M and 6 more authors..  (2004)  A novel mutation of WT1 exon 9 in a patient with Denys-Drash syndrome and pyloric stenosis..  Pediatric nephrology (Berlin, Germany),      [PMID:15349765]
40. Lachenmann, Marcel J MJ and 5 more authors..  (2004)  Why zinc fingers prefer zinc: ligand-field symmetry and the hidden thermodynamics of metal ion selectivity..  Biochemistry,    (9):   [PMID:15518539]
41. Smolen, Gromoslaw A GA, Vassileva, Maria T MT, Wells, Julie J, Matunis, Michael J MJ and Haber, Daniel A DA..  (2004)  SUMO-1 modification of the Wilms' tumor suppressor WT1..  Cancer research,    (1):   [PMID:15520190]
42. Markus, M Andrea MA and 9 more authors..  (2006)  WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo..  Experimental cell research,    (15):   [PMID:16934801]
43. Yang, L L, Han, Y Y, Suarez Saiz, F F, Saurez Saiz, F F and Minden, M D MD..  (2007)  A tumor suppressor and oncogene: the WT1 story..  Leukemia,      [PMID:17361230]
44. Stoll, Raphael R and 6 more authors..  (2007)  Structure of the Wilms tumor suppressor protein zinc finger domain bound to DNA..  Journal of molecular biology,    (5):   [PMID:17716689]
45. Suri, Mohnish M and 12 more authors..  (2007)  WT1 mutations in Meacham syndrome suggest a coelomic mesothelial origin of the cardiac and diaphragmatic malformations..  American journal of medical genetics. Part A,    (1):   [PMID:17853480]
46. Weiss, Tristen C TC and Romaniuk, Paul J PJ..  (2009)  Contribution of individual amino acids to the RNA binding activity of the Wilms' tumor suppressor protein WT1..  Biochemistry,    (13):   [PMID:19123921]
47. Rivera, Miguel N MN and 7 more authors..  (2009)  The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity..  Proceedings of the National Academy of Sciences of the United States of America,    (19):   [PMID:19416806]
48. Büscher, Anja K AK and 13 more authors..  (2010)  Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome..  Clinical journal of the American Society of Nephrology : CJASN,      [PMID:20798252]
49. Hashimoto, Hideharu H and 5 more authors..  (2014)  Wilms tumor protein recognizes 5-carboxylcytosine within a specific DNA sequence..  Genes & development,    (15):   [PMID:25258363]

Solution Calculators